Found 32 matching trials
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases NA This study is a single-center, open-label, single-arm, dose-escalation tria...
Show More Location
the second affiliated hospital Zhejiang University School of Medicine
Learn More & Join Trial
Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases EARLY_PHASE1 Evaluating the efficacy and safety of anti-CD19/BCMA CAR-NK Cells in Paedia...
Show More Location
Children's Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
A Study of Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic Malignancies PHASE1 It is a single-center, open-labeled, single-arm, non-randomized investigato...
Show More Location
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Learn More & Join Trial
Study of Anti-CD19/CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma EARLY_PHASE1 This is a single-centre, single-arm and open-label study to investigate the...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease EARLY_PHASE1 this is an investigator-initiated trial aimed at evaluating the efficacy an...
Show More Location
Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000
Learn More & Join Trial
Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma EARLY_PHASE1 This is a single-centre, single-arm and open-label study to investigate the...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia PHASE1 This study is a single arm clinical study to observe the safety ๏ผdose toler...
Show More Location
Hebei Yanda Ludaopei Hospital
Learn More & Join Trial
Anti-CD19 CAR NK Cell Therapy for R/R Non-Hodgkin Lymphoma. EARLY_PHASE1 Although the anti-CD19 CAR-T cell therapies have gained significant results...
Show More Location
Department of Hematology, Xinqiao Hospital
Learn More & Join Trial
A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) PHASE2 This study has 2 parts.
The main aim of Part 1 is to check for side effect...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis EARLY_PHASE1 A single-center, open-label dose-escalation design to evaluate the safety a...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial